Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY
· Real-Time Price · USD
0.50
-0.02 (-3.47%)
At close: May 15, 2025, 3:59 PM
0.50
-0.36%
After-hours: May 15, 2025, 04:44 PM EDT
-3.47% (1D)
| Bid | 0.49 |
| Market Cap | 43.37M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -31.71M |
| EPS (ttm) | -0.29 |
| PE Ratio (ttm) | -1.73 |
| Forward PE | -1.24 |
| Analyst | Buy |
| Ask | 0.55 |
| Volume | 436,197 |
| Avg. Volume (20D) | 286,931 |
| Open | 0.50 |
| Previous Close | 0.52 |
| Day's Range | 0.50 - 0.53 |
| 52-Week Range | 0.47 - 1.53 |
| Beta | 1.50 |
About ONCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ONCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ONCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+24.56%
Oncolytics Biotech shares are trading higher after...
Unlock content with
Pro Subscription
7 months ago
+18.22%
Oncolytics Biotech shares are trading higher after the company announced key progress and upcoming studies for breast and pancreatic cancer treatments while also preparing for an accelerated FDA approval path.
